USD 61.16
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | - CHF | 0.0% |
2022 | - USD | -100.0% |
2021 | 4384.40 USD | -95.83% |
2020 | 105.2 Thousand USD | -33.41% |
2019 | 158 Thousand USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 FY | - CHF | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q4 | - CHF | 0.0% |
2022 Q3 | - USD | -100.0% |
2022 FY | - USD | -100.0% |
2022 Q4 | - USD | 0.0% |
2022 Q2 | 11.5 Thousand USD | 0.0% |
2021 FY | 4384.40 USD | -95.83% |
2020 FY | 105.2 Thousand USD | -33.41% |
2019 FY | 158 Thousand USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
American Medical Technologies Inc. | - USD | NaN% |
Ansell Limited | 705.27 Million USD | 100.0% |
Ansell Limited | 706.6 Million USD | 100.0% |
BG Medicine, Inc. | - USD | NaN% |
Biotage AB (publ) | 22.41 Million USD | 100.0% |
BioLife Sciences Inc. | - USD | NaN% |
CB Scientific, Inc. | - USD | NaN% |
Psykey, Inc. | 625 Thousand USD | 100.0% |
ConvaTec Group Plc | 1.22 Billion USD | 100.0% |
ConvaTec Group Plc | 1.22 Billion USD | 100.0% |
Encision Inc. | 67.33 Thousand USD | 100.0% |
Golden Valley Development, Inc | - USD | NaN% |
Hear AtLast Holdings, Inc. | - USD | NaN% |
Innovative MedTech Inc. | 382.83 Thousand USD | 100.0% |
LifePoint, Inc. | 151.73 Thousand USD | 100.0% |
Medite Cancer Diagnostics, Inc. | 4.91 Million USD | 100.0% |
Paradigm Medical Industries, Inc. | 615 Thousand USD | 100.0% |
QuantRx Biomedical Corporation | - USD | NaN% |
Remedent, Inc. | - USD | NaN% |
Reflect Scientific, Inc. | 179.96 Thousand USD | 100.0% |
SmileDirectClub, Inc. | 849.37 Million USD | 100.0% |
Sector 10, Inc. | - USD | NaN% |
Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 100.0% |
SheerVision, Inc. | - USD | NaN% |
United Health Products, Inc. | 48.48 Thousand USD | 100.0% |
Vasamed, Inc. | 18.95 Thousand USD | 100.0% |
Wearable Health Solutions, Inc. | 18.46 Thousand USD | 100.0% |
Yubo International Biotech Limited | 390.44 Thousand USD | 100.0% |